T. W. is receiving the chemotherapy protocol for Non-Hodgkin…
T. W. is receiving the chemotherapy protocol for Non-Hodgkin’s Lymphoma. Following the second cycle of treatment, the physician adds Neupogen (filgrastim), a colony-stimulating factor, to the regimen. The nurse would explain to T. W. that the Neupogen will:
Read DetailsA lab technician had an occupational exposure to HIV via an…
A lab technician had an occupational exposure to HIV via an accidental needle stick from a HIV+ patient. The initial ELISA test was negative. The lab technician is in the Employee Health Department for the 6 week follow-up ELISA test; those results were also negative. The lab technician asks the nurse what these findings mean. Which of the following represents the best response from the nurse to the lab technician?
Read Details